Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin maintenance therapy in high-risk bone sarcomas
2024-515639-32-00Phase 2Completed
- Sponsor
- Istituto Ortopedico Rizzoli
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of metformin in bone cancer, osteosarcoma (OS) and Ewing sarcoma of bone, sponsored by Istituto Ortopedico Rizzoli. Primary endpoint: Event-free survival. Started Jul 2024; status: completed.
02
Drugs
metformin
03
Conditions
bone cancerosteosarcoma (OS)Ewing sarcoma of bone
Beyond the preview
Go deeper on 2024-515639-32-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515639-32-00.